Self-Assembled Micelles Based on Ginsenoside Rg5 for the Targeted Treatment of PTX-Resistant Tumors
Molecular Pharmaceutics · 2024
DOI: 10.1021/acs.molpharmaceut.4c00204 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, 2024. Verfasst von Feiyan Gao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Medical Research Institute, College of Pharmaceutical Sciences, Southwest University, Chongqing 400715, China. Hauptthemen laut MEDLINE: Micelles, Ginsenosides, Paclitaxel, Drug Resistance, Neoplasm. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Chongqing University, Chongqing Municipal Education Commission, Natural Science Foundation of Chongqing Municipality.
Abstract (Originalsprache)
Paclitaxel (PTX) is one of the first-line drugs for prostate cancer (PC) treatment. However, the poor water solubility, inadequate specific targeting ability, multidrug resistance, and severe neurotoxicity are far from being fully resolved, despite diverse PTX formulations in the market, such as the gold-standard PTX albumin nanoparticle (Abraxane) and polymer micelles (Genexol-PM). Some studies attempting to solve the multiple problems of chemotherapy delivery fall into the trap of an extremely complicated formulation design and sacrifice druggability. To better address these issues, this study designed an efficient, toxicity-reduced paclitaxel-ginsenoside polymeric micelle (RPM). With the aid of the inherent amphiphilic molecular structure and pharmacological effects of ginsenoside Rg5, the prepared RPM enhances the water solubility and active targeting of PTX, inhibiting chemotherapy resistance in cancer cells. Moreover, the polymeric micelles demonstrated favorable anti-inflammatory and neuroprotective effects, providing ideas for the development of new clinical anti-PC preparations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Research Institute, College of Pharmaceutical Sciences, Southwest University, Chongqing 400715, China.
- Department of Urology, Urologic Surgery Center, Xinqiao Hospital, Third Military Medical University (Army Medical University), Chongqing 400037, China.
- Division of Pharmaceutics, National Pharmaceutical Engineering Center for Solid Preparation in Chinese Herbal Medicine, Jiangxi University of Traditional Chinese Medicine, Nanchang 330006, China.
- State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences (ICMS), University of Macau, Macau, China.
ORCID-Profile: Chong Li
Förderung
- Chongqing University
- Chongqing Municipal Education Commission
- Natural Science Foundation of Chongqing Municipality
- Major Discipline Academic and Technical Leaders Training Program of Jiangxi Province
- National Natural Science Foundation of China
Zitieren
APA
Gao, F., Ma, Z., Luo, X., Wang, Y., Liu, X., Tang, M., Chen, J., Tu, L., Ouyang, D., Zheng, J., & Li, C. (2024). Self-Assembled Micelles Based on Ginsenoside Rg5 for the Targeted Treatment of PTX-Resistant Tumors. Molecular Pharmaceutics. https://doi.org/10.1021/acs.molpharmaceut.4c00204
Vancouver
Gao F, Ma Z, Luo X, Wang Y, Liu X, Tang M, et al. Self-Assembled Micelles Based on Ginsenoside Rg5 for the Targeted Treatment of PTX-Resistant Tumors. Molecular Pharmaceutics. 2024. doi:10.1021/acs.molpharmaceut.4c00204
BibTeX
@article{Gao2024,
author = {Gao, Feiyan and Ma, Zhongyi and Luo, Xing and Wang, Yahua and Liu, Xinlong and Tang, Mei and Chen, Junyu and Tu, Liangxing and Ouyang, Defang and Zheng, Ji and Li, Chong},
title = {Self-Assembled Micelles Based on Ginsenoside Rg5 for the Targeted Treatment of PTX-Resistant Tumors},
journal = {Molecular Pharmaceutics},
year = {2024},
doi = {10.1021/acs.molpharmaceut.4c00204}
}
EUVIMED